pmc-enju-pas Home  

PMC:3218875 / 24005-25236 JSONTXT 24 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function IAV-Glycan

Id Subject Object Predicate Lexical cue
T12920 0-5 VB denotes Using
T12921 6-21 NN denotes oligonucleotide
T12922 22-32 NN denotes microarray
T12923 33-41 NN denotes analysis
T12924 41-42 -COMMA- denotes ,
T12925 43-49 NN denotes ABIN-1
T12926 50-53 VB denotes was
T12927 54-64 VB denotes identified
T12928 65-70 IN denotes among
T12929 71-82 JJ denotes TNF-induced
T12930 83-88 NN denotes genes
T12931 89-91 IN denotes in
T12932 92-97 JJ denotes human
T12933 98-110 NN denotes synoviocytes
T12934 110-111 -COMMA- denotes ,
T12935 112-115 CC denotes and
T12936 116-120 JJ denotes high
T12937 121-127 NN denotes levels
T12938 128-130 IN denotes of
T12939 131-137 NN denotes ABIN-1
T12940 138-142 NN denotes mRNA
T12941 143-147 VB denotes were
T12942 148-156 VB denotes detected
T12943 157-159 IN denotes in
T12944 160-162 NN denotes RA
T12945 163-169 NN denotes tissue
T12946 170-178 NN denotes biopsies
T12947 178-179 -COMMA- denotes ,
T12948 180-190 VB denotes indicating
T12949 191-192 DT denotes a
T12950 193-202 JJ denotes potential
T12951 203-207 NN denotes role
T12952 208-211 IN denotes for
T12953 212-218 NN denotes ABIN-1
T12954 218-219 -COMMA- denotes ,
T12955 220-228 RB denotes together
T12956 229-233 IN denotes with
T12957 234-237 NN denotes A20
T12958 237-238 -COMMA- denotes ,
T12959 239-241 IN denotes in
T12960 242-245 DT denotes the
T12961 246-254 JJ denotes negative
T12962 255-263 NN denotes feedback
T12963 264-274 NN denotes regulation
T12964 275-277 IN denotes of
T12965 278-283 NN denotes NF-κB
T12966 284-294 NN denotes signalling
T12967 295-298 CC denotes and
T12968 299-302 DT denotes the
T12969 303-315 NN denotes pathogenesis
T12970 316-318 IN denotes of
T12971 319-321 NN denotes RA
T12972 322-323 -LRB- denotes [
T12973 323-325 CD denotes 59
T12974 325-326 -RRB- denotes ]
T12975 328-330 IN denotes In
T12976 331-332 DT denotes a
T12977 333-339 JJ denotes recent
T12978 340-345 NN denotes study
T12979 345-346 -COMMA- denotes ,
T12980 347-357 NN denotes inhibition
T12981 358-360 IN denotes of
T12982 361-364 NN denotes TLR
T12983 365-374 NN denotes responses
T12984 375-377 IN denotes by
T12985 378-392 NN denotes immunoreceptor
T12986 393-407 JJ denotes tyrosine-based
T12987 408-418 NN denotes activation
T12988 419-424 NN denotes motif
T12989 425-426 -LRB- denotes (
T12990 426-430 NN denotes ITAM
T12991 430-431 -RRB- denotes )
T12992 431-439 JJ denotes -coupled
T12993 440-449 NN denotes receptors
T12994 450-453 VB denotes was
T12995 454-459 VB denotes shown
T12996 460-462 TO denotes to
T12997 463-469 VB denotes depend
T12998 470-472 IN denotes on
T12999 473-476 DT denotes the
T13000 477-487 NN denotes expression
T13001 488-490 IN denotes of
T13002 491-494 DT denotes the
T13003 495-500 NN denotes NF-κB
T13004 501-511 JJ denotes inhibitory
T13005 512-520 NN denotes proteins
T13006 521-527 NN denotes ABIN-3
T13007 528-531 CC denotes and
T13008 532-535 NN denotes A20
T13009 537-545 RB denotes Moreover
T13010 545-546 -COMMA- denotes ,
T13011 547-551 DT denotes this
T13012 552-562 JJ denotes protective
T13013 563-569 NN denotes effect
T13014 570-572 IN denotes of
T13015 573-576 DT denotes the
T13016 577-581 NNP denotes ITAM
T13017 582-585 VB denotes was
T13018 586-594 RB denotes strongly
T13019 595-605 VB denotes suppressed
T13020 606-608 IN denotes in
T13021 609-621 JJ denotes inflammatory
T13022 622-631 NN denotes arthritis
T13023 632-640 JJ denotes synovial
T13024 641-652 NN denotes macrophages
T13025 653-654 -LRB- denotes [
T13026 654-656 CD denotes 60
T13027 656-657 -RRB- denotes ]
T13028 659-672 RB denotes Interestingly
T13029 672-673 -COMMA- denotes ,
T13030 674-680 NN denotes ABIN-1
T13031 681-694 NN denotes polymorphisms
T13032 695-699 VB denotes have
T13033 700-704 VB denotes been
T13034 705-715 VB denotes associated
T13035 716-720 IN denotes with
T13036 721-730 NN denotes psoriasis
T13037 731-734 CC denotes and
T13038 735-743 JJ denotes systemic
T13039 744-749 NN denotes lupus
T13040 750-763 NN denotes erythematosus
T13041 764-766 IN denotes in
T13042 767-773 NN denotes humans
T13043 774-775 -LRB- denotes [
T13044 775-780 CD denotes 61,62
T13045 780-781 -RRB- denotes ]
T13046 783-784 DT denotes A
T13047 785-789 JJ denotes high
T13048 790-796 NN denotes degree
T13049 797-799 IN denotes of
T13050 800-807 NN denotes overlap
T13051 808-815 IN denotes between
T13052 816-824 JJ denotes systemic
T13053 825-830 NN denotes lupus
T13054 831-844 NN denotes erythematosus
T13055 845-848 CC denotes and
T13056 849-851 NN denotes RA
T13057 852-866 NN denotes susceptibility
T13058 867-871 NN denotes loci
T13059 872-877 MD denotes might
T13060 878-880 VB denotes be
T13061 881-889 VB denotes expected
T13062 890-892 IN denotes as
T13063 893-896 DT denotes the
T13064 897-900 CD denotes two
T13065 901-909 NN denotes diseases
T13066 910-914 VB denotes show
T13067 915-919 DT denotes some
T13068 920-928 JJ denotes clinical
T13069 929-936 NN denotes overlap
T13070 937-939 IN denotes in
T13071 940-945 JJ denotes joint
T13072 946-957 NN denotes involvement
T13073 957-958 -COMMA- denotes ,
T13074 959-971 NN denotes autoantibody
T13075 972-982 NN denotes production
T13076 982-983 -COMMA- denotes ,
T13077 984-992 JJ denotes systemic
T13078 993-1001 NN denotes features
T13079 1002-1005 CC denotes and
T13080 1006-1014 NN denotes response
T13081 1015-1017 TO denotes to
T13082 1018-1028 NN denotes treatments
T13083 1029-1033 JJ denotes such
T13084 1034-1036 IN denotes as
T13085 1037-1043 NN denotes B-cell
T13086 1044-1053 NN denotes depletion
T13087 1054-1055 -LRB- denotes (
T13088 1055-1064 NN denotes rituximab
T13089 1064-1065 -RRB- denotes )
T13090 1067-1069 PRP denotes It
T13091 1070-1074 MD denotes will
T13092 1075-1084 RB denotes therefore
T13093 1085-1087 VB denotes be
T13094 1088-1099 JJ denotes interesting
T13095 1100-1102 TO denotes to
T13096 1103-1114 VB denotes investigate
T13097 1115-1122 IN denotes whether
T13098 1123-1127 NN denotes SNPs
T13099 1128-1132 WDT denotes that
T13100 1133-1137 VB denotes have
T13101 1138-1142 VB denotes been
T13102 1143-1151 VB denotes reported
T13103 1152-1154 TO denotes to
T13104 1155-1157 VB denotes be
T13105 1158-1168 VB denotes associated
T13106 1169-1173 IN denotes with
T13107 1174-1182 JJ denotes systemic
T13108 1183-1188 NN denotes lupus
T13109 1189-1202 NN denotes erythematosus
T13110 1203-1206 VB denotes are
T13111 1207-1211 RB denotes also
T13112 1212-1222 VB denotes associated
T13113 1223-1227 IN denotes with
T13114 1228-1230 NN denotes RA
R8555 T12923 T12920 arg2Of analysis,Using
R8556 T12923 T12921 arg1Of analysis,oligonucleotide
R8557 T12923 T12922 arg1Of analysis,microarray
R8558 T12925 T12920 arg1Of ABIN-1,Using
R8559 T12925 T12926 arg1Of ABIN-1,was
R8560 T12925 T12927 arg2Of ABIN-1,identified
R8561 T12927 T12926 arg2Of identified,was
R8562 T12927 T12928 arg1Of identified,among
R8563 T12927 T12931 arg1Of identified,in
R8564 T12927 T12935 arg1Of identified,and
R8565 T12930 T12928 arg2Of genes,among
R8566 T12930 T12929 arg1Of genes,TNF-induced
R8567 T12933 T12931 arg2Of synoviocytes,in
R8568 T12933 T12932 arg1Of synoviocytes,human
R8569 T12935 T12920 modOf and,Using
R8570 T12935 T12924 arg1Of and,","
R8571 T12935 T12934 arg1Of and,","
R8572 T12937 T12936 arg1Of levels,high
R8573 T12937 T12938 arg1Of levels,of
R8574 T12937 T12941 arg1Of levels,were
R8575 T12937 T12942 arg2Of levels,detected
R8576 T12940 T12938 arg2Of mRNA,of
R8577 T12940 T12939 arg1Of mRNA,ABIN-1
R8578 T12942 T12935 arg2Of detected,and
R8579 T12942 T12941 arg2Of detected,were
R8580 T12942 T12943 arg1Of detected,in
R8581 T12942 T12947 arg1Of detected,","
R8582 T12942 T12948 modOf detected,indicating
R8583 T12946 T12943 arg2Of biopsies,in
R8584 T12946 T12944 arg1Of biopsies,RA
R8585 T12946 T12945 arg1Of biopsies,tissue
R8586 T12951 T12948 arg2Of role,indicating
R8587 T12951 T12949 arg1Of role,a
R8588 T12951 T12950 arg1Of role,potential
R8589 T12951 T12952 arg1Of role,for
R8590 T12951 T12956 arg1Of role,with
R8591 T12951 T12958 arg1Of role,","
R8592 T12951 T12959 arg1Of role,in
R8593 T12952 T12954 arg1Of for,","
R8594 T12953 T12952 arg2Of ABIN-1,for
R8595 T12956 T12954 arg2Of with,","
R8596 T12956 T12955 arg1Of with,together
R8597 T12957 T12956 arg2Of A20,with
R8598 T12963 T12960 arg1Of regulation,the
R8599 T12963 T12961 arg1Of regulation,negative
R8600 T12963 T12962 arg1Of regulation,feedback
R8601 T12963 T12964 arg1Of regulation,of
R8602 T12963 T12967 arg1Of regulation,and
R8603 T12966 T12964 arg2Of signalling,of
R8604 T12966 T12965 arg1Of signalling,NF-κB
R8605 T12967 T12959 arg2Of and,in
R8606 T12969 T12967 arg2Of pathogenesis,and
R8607 T12969 T12968 arg1Of pathogenesis,the
R8608 T12969 T12970 arg1Of pathogenesis,of
R8609 T12971 T12970 arg2Of RA,of
R8610 T12971 T12972 arg1Of RA,[
R8611 T12973 T12972 arg2Of 59,[
R8612 T12974 T12972 arg3Of ],[
R8613 T12978 T12975 arg2Of study,In
R8614 T12978 T12976 arg1Of study,a
R8615 T12978 T12977 arg1Of study,recent
R8616 T12980 T12981 arg1Of inhibition,of
R8617 T12980 T12984 arg1Of inhibition,by
R8618 T12980 T12994 arg1Of inhibition,was
R8619 T12980 T12995 arg2Of inhibition,shown
R8620 T12980 T12997 arg1Of inhibition,depend
R8621 T12983 T12981 arg2Of responses,of
R8622 T12983 T12982 arg1Of responses,TLR
R8623 T12990 T12989 arg2Of ITAM,(
R8624 T12991 T12989 arg3Of ),(
R8625 T12993 T12984 arg2Of receptors,by
R8626 T12993 T12985 arg1Of receptors,immunoreceptor
R8627 T12993 T12986 arg1Of receptors,tyrosine-based
R8628 T12993 T12987 arg1Of receptors,activation
R8629 T12993 T12988 arg1Of receptors,motif
R8630 T12993 T12989 arg1Of receptors,(
R8631 T12993 T12992 arg1Of receptors,-coupled
R8632 T12995 T12975 arg1Of shown,In
R8633 T12995 T12979 arg1Of shown,","
R8634 T12995 T12994 arg2Of shown,was
R8635 T12997 T12995 arg3Of depend,shown
R8636 T12997 T12996 arg1Of depend,to
R8637 T12997 T12998 arg1Of depend,on
R8638 T13000 T12998 arg2Of expression,on
R8639 T13000 T12999 arg1Of expression,the
R8640 T13000 T13001 arg1Of expression,of
R8641 T13005 T13002 arg1Of proteins,the
R8642 T13005 T13003 arg1Of proteins,NF-κB
R8643 T13005 T13004 arg1Of proteins,inhibitory
R8644 T13006 T13007 arg1Of ABIN-3,and
R8645 T13007 T13001 arg2Of and,of
R8646 T13007 T13005 arg1Of and,proteins
R8647 T13008 T13007 arg2Of A20,and
R8648 T13013 T13011 arg1Of effect,this
R8649 T13013 T13012 arg1Of effect,protective
R8650 T13013 T13014 arg1Of effect,of
R8651 T13013 T13017 arg1Of effect,was
R8652 T13013 T13019 arg2Of effect,suppressed
R8653 T13016 T13014 arg2Of ITAM,of
R8654 T13016 T13015 arg1Of ITAM,the
R8655 T13019 T13009 arg1Of suppressed,Moreover
R8656 T13019 T13010 arg1Of suppressed,","
R8657 T13019 T13017 arg2Of suppressed,was
R8658 T13019 T13018 arg1Of suppressed,strongly
R8659 T13019 T13020 arg1Of suppressed,in
R8660 T13024 T13020 arg2Of macrophages,in
R8661 T13024 T13021 arg1Of macrophages,inflammatory
R8662 T13024 T13022 arg1Of macrophages,arthritis
R8663 T13024 T13023 arg1Of macrophages,synovial
R8664 T13024 T13025 arg1Of macrophages,[
R8665 T13026 T13025 arg2Of 60,[
R8666 T13027 T13025 arg3Of ],[
R8667 T13031 T13030 arg1Of polymorphisms,ABIN-1
R8668 T13031 T13032 arg1Of polymorphisms,have
R8669 T13031 T13033 arg1Of polymorphisms,been
R8670 T13031 T13034 arg2Of polymorphisms,associated
R8671 T13034 T13028 arg1Of associated,Interestingly
R8672 T13034 T13029 arg1Of associated,","
R8673 T13034 T13032 arg2Of associated,have
R8674 T13034 T13033 arg2Of associated,been
R8675 T13034 T13035 arg1Of associated,with
R8676 T13036 T13037 arg1Of psoriasis,and
R8677 T13037 T13035 arg2Of and,with
R8678 T13037 T13041 arg1Of and,in
R8679 T13040 T13037 arg2Of erythematosus,and
R8680 T13040 T13038 arg1Of erythematosus,systemic
R8681 T13040 T13039 arg1Of erythematosus,lupus
R8682 T13042 T13041 arg2Of humans,in
R8683 T13042 T13043 arg1Of humans,[
R8684 T13044 T13043 arg2Of "61,62",[
R8685 T13045 T13043 arg3Of ],[
R8686 T13048 T13046 arg1Of degree,A
R8687 T13048 T13047 arg1Of degree,high
R8688 T13048 T13049 arg1Of degree,of
R8689 T13048 T13051 arg1Of degree,between
R8690 T13048 T13059 arg1Of degree,might
R8691 T13048 T13060 arg1Of degree,be
R8692 T13048 T13061 arg2Of degree,expected
R8693 T13050 T13049 arg2Of overlap,of
R8694 T13054 T13052 arg1Of erythematosus,systemic
R8695 T13054 T13053 arg1Of erythematosus,lupus
R8696 T13054 T13055 arg1Of erythematosus,and
R8697 T13055 T13051 arg2Of and,between
R8698 T13058 T13055 arg2Of loci,and
R8699 T13058 T13056 arg1Of loci,RA
R8700 T13058 T13057 arg1Of loci,susceptibility
R8701 T13061 T13059 arg2Of expected,might
R8702 T13061 T13060 arg2Of expected,be
R8703 T13061 T13062 arg1Of expected,as
R8704 T13065 T13063 arg1Of diseases,the
R8705 T13065 T13064 arg1Of diseases,two
R8706 T13065 T13066 arg1Of diseases,show
R8707 T13066 T13062 arg2Of show,as
R8708 T13066 T13070 arg1Of show,in
R8709 T13069 T13066 arg2Of overlap,show
R8710 T13069 T13067 arg1Of overlap,some
R8711 T13069 T13068 arg1Of overlap,clinical
R8712 T13072 T13071 arg1Of involvement,joint
R8713 T13072 T13073 arg1Of involvement,","
R8714 T13073 T13076 arg1Of ",",","
R8715 T13075 T13073 arg2Of production,","
R8716 T13075 T13074 arg1Of production,autoantibody
R8717 T13076 T13079 arg1Of ",",and
R8718 T13078 T13076 arg2Of features,","
R8719 T13078 T13077 arg1Of features,systemic
R8720 T13079 T13070 arg2Of and,in
R8721 T13080 T13079 arg2Of response,and
R8722 T13080 T13081 arg1Of response,to
R8723 T13082 T13081 arg2Of treatments,to
R8724 T13082 T13084 arg1Of treatments,as
R8725 T13084 T13083 arg1Of as,such
R8726 T13086 T13084 arg2Of depletion,as
R8727 T13086 T13085 arg1Of depletion,B-cell
R8728 T13086 T13087 arg1Of depletion,(
R8729 T13088 T13087 arg2Of rituximab,(
R8730 T13089 T13087 arg3Of ),(
R8731 T13093 T13091 arg2Of be,will
R8732 T13093 T13092 arg1Of be,therefore
R8733 T13094 T13093 arg2Of interesting,be
R8734 T13096 T13090 arg1Of investigate,It
R8735 T13096 T13091 arg1Of investigate,will
R8736 T13096 T13093 arg1Of investigate,be
R8737 T13096 T13094 arg1Of investigate,interesting
R8738 T13096 T13095 arg1Of investigate,to
R8739 T13098 T13099 arg1Of SNPs,that
R8740 T13098 T13100 arg1Of SNPs,have
R8741 T13098 T13101 arg1Of SNPs,been
R8742 T13098 T13102 arg2Of SNPs,reported
R8743 T13098 T13104 arg1Of SNPs,be
R8744 T13098 T13105 arg2Of SNPs,associated
R8745 T13098 T13110 arg1Of SNPs,are
R8746 T13098 T13112 arg2Of SNPs,associated
R8747 T13102 T13100 arg2Of reported,have
R8748 T13102 T13101 arg2Of reported,been
R8749 T13105 T13102 arg3Of associated,reported
R8750 T13105 T13103 arg1Of associated,to
R8751 T13105 T13104 arg2Of associated,be
R8752 T13105 T13106 arg1Of associated,with
R8753 T13109 T13106 arg2Of erythematosus,with
R8754 T13109 T13107 arg1Of erythematosus,systemic
R8755 T13109 T13108 arg1Of erythematosus,lupus
R8756 T13112 T13096 arg2Of associated,investigate
R8757 T13112 T13097 arg1Of associated,whether
R8758 T13112 T13110 arg2Of associated,are
R8759 T13112 T13111 arg1Of associated,also
R8760 T13112 T13113 arg1Of associated,with
R8761 T13114 T13113 arg2Of RA,with